מדינה: אירלנד
שפה: אנגלית
מקור: HPRA (Health Products Regulatory Authority)
Marbofloxacin
Laboratorios SYVA, S.A.U
QJ01MA93
Marbofloxacin
100 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Pigs
marbofloxacin
Antibacterial
Authorised
2012-11-23
Health Products Regulatory Authority 17 November 2017 CRN000V8D Page 1 of 7 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Marbosyva 100 mg/ml solution for injection for cattle and pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Metacresol 2 mg Monothioglycerol 1 mg Disodium edetate 0.1 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear, yellowish solution 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In cattle: - Treatment of respiratory infections caused by marbofloxacin-susceptible strains of _Histophilus somni_, _Mannheimia haemolytica_, _Pasteurella multocida _and _Mycoplasma _ _bovis_. - Treatment of acute forms of mastitis induced by marbofloxacin-susceptible _Escherichia coli_ strains, during lactation. In pigs (sows): - Treatment of Postpartum Dysgalactiae Syndrome, PDS (Metritis Mastitis Agalactia Syndrome) caused by marbofloxacin-susceptible bacterial strains. 4.3 CONTRAINDICATIONS Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). Health Products Regulatory Authority 17 November 2017 CRN000V8D Page 2 of 7 Do not use in cases of hypersensitivity to the active substance, to any other quinolone or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinol קרא את המסמך השלם